Lilly to sell obesity drugs directly on Hims & Hers site
Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth... Covered by 3 outlets: 1 lean left, 2 are centre.
Lean: Center
Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
Quartz Eli Lilly is partnering with Hims & Hers to sell its weight loss drugs
The agreement covers Zepbound and Foundayo for patients who pay out of pocket through the telehealth platform
Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Medscape Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth... Reuters Health Information
Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Coverage breakdown
Funding
Corporate
Countries
United States
United Kingdom
Media ownership
Independent
G/O Media
Thomson Reuters
Avg reliability76
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 63 (Corroborated)
Propaganda risk: 0
Trending: Low
Sources: 3
Reliability: 76
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0
